• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to footer
  • News
  • Lifestyle
  • Wellness
  • Cuisine
  • Product Reviews
  • Subscribe
Cannabis News and Culture Magazine

Cannabis News and Culture Magazine

Cannabis News and Culture Magazine

Emerald Media News Subscription
  • Print Magazines
  • 100+ Minority-Owned Companies to Support
  • No Pipe, No Problem
  • Blunt vs. Joint
  • The Cost of Cannabis in Each State
  • Calculating Your Edibles Dosage
  • Flintts Mouthwatering Mints

Groundbreaking Research Comes Close to Unlocking a Diagnosis for CTE, One Brain at a Time

August 27, 2018 by Emerald Media Group Leave a Comment

This information was provided by cmwmedia

Send your Press Release here.

The CTE Center at Boston University’s School of Medicine is closing in on a workable diagnosis for the neurodegenerative brain disease CTE, after studying the brains of nearly 500 deceased players who have donated their brains to science.

CTE, or Chronic Traumatic Encephalopathy, is a degenerative neurological disease caused by repeated head trauma and only diagnosable with certainty in post-mortem examinations and can lead to symptoms like violent mood swings, depression and other cognitive difficulties.

Ann McKee, chief of neuropathology at the VA Boston Healthcare System, says “If we can diagnose it, we can monitor it and test therapies to see if they’re effective in treating this disease… It would really dramatically increase our ability to point out genetic susceptibilities for this.”

While McKee is working with her team for a feasible way to diagnose and predict genetic markers for CTE, researchers at Kannalife Sciences are working to create a workable treatment for the disease.

Kannalife Sciences (“Kannalife”) is the phyto-medical company that specializes in the research & development of pharmacological products derived from botanical sources. Kannalife’s exclusive license to the patent “Cannabinoids as Antioxidants and Neuroprotectants” (the “‘507 Patent”) allows the company to dogroundbreaking research and develop cannabinoid-based treatments for CTE, which is a degenerative brain disease often found in contact sports athletes.KannaLife hopes their company’s research will pave the way for the development of cannabidiol-based (CBD) drugs to help protect the brain.

Filed Under: Press Release Tagged With: Press

Reader Interactions

Leave a Reply

Your email address will not be published. Required fields are marked *

Primary Sidebar

  • Facebook
  • Instagram
  • LinkedIn
  • Twitter
  • YouTube

Advertise Here

Categories

Sustainability

seaweed naturals

SeaWeed Naturals Combines the Power of Seaweed with Cannabis to Further Ocean Restoration

April 3, 2022 By Maggie Horton

fungi climate change

Research Finds Fungi Help Ease Climate Change and Benefit the Environment

March 30, 2022 By Julia Meyer

climate crisis and the pandemic

“We Can Act:” What Bending the COVID-19 Curve Teaches Us About the Climate Crisis

April 21, 2020 By Melissa Hutsell

Footer

  • Subscribe
  • About
  • Contact
  • Privacy
  • Press

Recent

  • Priscilla Vilchis and Lil Kim Launch Aphrodisiak: A Cannabis Brand Focused on Sensuality, Social Justice, and Inclusivity
  • First Latina CEO of a Cannabis Company Partners with Music Industry Trailblazer Lil Kim to Launch Aphrodisiak Brand
  • Aphrodisiak: The New Female-Led Cannabis Brand Empowering Women and Promoting Inclusivity
  • Las Vegas Welcomes Aphrodisiak
  • HighOnLove – Taking Pleasure to New Heights

Search

Copyright © 2023 · The Emerald™ · News & Lifestyle Magazine

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in settings.

Cannabis News and Culture Magazine
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.